Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomography - Tahara, Nobuhiro; Yamagishi, Sho-ichi; Takeuchi, Masayoshi; Honda, Akihiro; Tahara, Atsuko; Nitta, Yoshikazu; Kodama, Norihiro; Mizoguchi, Minori; Kaida, Hayato; Ishibashi, Masatoshi; Hayabuchi, Naofumi; Matsui, Takanori; et al. (Diabetes care, 2012)
Keywords: Acute coronary syndromes; Age; Aged; Antineoplastic Agents - therapeutic use; Atherosclerosis; Atherosclerosis - blood; Atherosclerosis - diagnosis; Atherosclerosis - diagnostic imaging; Biological and medical sciences; Blood pressure; Cardiovascular disease; Cytokines; Design; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Family medical history; Female; Fluorodeoxyglucose F18; Glucose; Glycation End Products, Advanced - blood; Humans; Insulin; Insulin resistance; Male; Medical imaging; Medical sciences; Medicine; Metabolic diseases; Methods; Middle Aged; Miscellaneous; Original Research; Positron-Emission Tomography - methods; Proteins; Public health. Hygiene; Public health. Hygiene-occupational medicine; Scanners; Radionuclide study; Human; 2-deoxy-2-fluoroglucose; Nutrition; Metabolic diseases; Inflammation; Advanced glycation end products; Association; Blood vessel; Clinical biology; Circulatory system; Derived product; Positron emission tomography; Endocrinology; Emission tomography